Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study C: 4-Drug FDC for Pulmonary Tuberculosis
NCT00216333Phase 4Unknown
- Sponsor
- International Union Against Tuberculosis and Lung Disease
- Start
- Dec 2003
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 4 trial of ethambutol, isoniazid, rifampicin, pyrazinamide in pulmonary tuberculosis (TB), sponsored by International Union Against Tuberculosis and Lung Disease. Status: unknown.
02
Drugs
ethambutolisoniazidrifampicinpyrazinamide
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT00216333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216333.